Proposed Collection; 60-Day Comment Request; iWin: Navigating Your Path to Well-Being, 10639-10640 [2016-04364]
Download as PDF
<![CDATA[
10639
Federal Register / Vol. 81, No. 40 / Tuesday, March 1, 2016 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Number of
respondents
per year
Form name
Phase 2: Summer Curriculum
in Cancer Prevention.
Phase 1: Women’s Cancer
Program Summit.
Phase 2: Women’s Cancer
Program Summit.
Phase 1: Regional Grant Writing and Peer Review Workshop.
Phase 2: Regional Grant Writing and Peer Review Workshop.
Phase 1: Workshops on Tobacco Control.
Phase 2: Workshops on Tobacco Control.
Totals ..................................................
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR13–189:
Imaging and Biomarkers for Early Cancer
Detection.
Date: March 22, 2016.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
VerDate Sep<11>2014
20:18 Feb 29, 2016
Jkt 238001
1
30/60
14
140
1
20/60
47
140
1
20/60
47
150
1
30/60
75
60
1
30/60
30
180
1
30/60
90
90
1
30/60
45
2,317
2,317
........................
941
Contact Person: Chiayeng Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Room 5213, MSC 7852, Bethesda, MD 20892,
301–435–2397, chiayeng.wang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
[FR Doc. 2016–04363 Filed 2–29–16; 8:45 am]
Dated: February 25, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–04446 Filed 2–29–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; iWin: Navigating Your Path to
Well-Being
Summary: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Institute on Drug Abuse
(NIDA), National Institutes of Health
(NIH), will publish periodic summaries
of proposed projects to be submitted to
the Office of Management and Budget
(OMB) for review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited to address one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Total annual
burden hours
27
..................................................
Dated: February 10, 2016.
Karla Bailey,
Project Clearance Liaison, National Cancer
Institute, NIH.
Average
burden per
response
(in hours)
Number of
responses per
respondent
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments And For
Further Information: To obtain a copy of
the data collection plans and
instruments, submit comments in
writing, or request more information on
the proposed project, contact: Dr.
Belinda Sims, Health Scientist, DESPR,
PRB, NIDA, NIH, 6001 Executive
Boulevard, Room 5153, Bethesda,
Maryland 20892, or call non-toll-free
number (301) 402–1533, or Email your
request, including your address to:
bsims@nida.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: iWin: Navigating
your Path to Well-Being, 0925–NEW,
National Institute on Drug Abuse
(NIDA), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The overarching objective of
this proposal is to conduct a
E:\FR\FM\01MRN1.SGM
01MRN1
10640
Federal Register / Vol. 81, No. 40 / Tuesday, March 1, 2016 / Notices
randomized trial to evaluate the
effectiveness of the Individual WellBeing Navigator (iWin) mobile
application, a substance abuse
prevention and well-being enhancement
program designed specifically for
military personnel. This mobile
application provides an innovative,
tailored mobile application using best
practices in behavior change science
and innovative technology to assist
military personnel in preventing
substance abuse and enhancing wellbeing by providing them with the most
appropriate intervention content at the
right time. It integrates Trans-theoretical
control group) by 3 Occasions with
repeated measures across occasions.
Once shown to be effective, the iWin
program will assist organizations that
serve military personnel to meet the
directives of both the Department of
Defense and the Chairman of the Joint
Chiefs of Staff indicating that
prevention programs be evidence based,
evaluated by the specified populations
and address full Total Force Fitness
paradigm rather than a single behavior.
OMB approval is requested for 1 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 1,557.
Model of Behavior Change based
tailoring, SMS messaging, stage of
change matched activities, and engaging
game-like features in a cutting edge
multiple behavior change program. The
first year of this project will focus on the
completion of development and beta
testing of the app. In year 2, the efficacy
of the iWin program will be determined
by tests of statistical significance
indicating that participants in the
Treatment condition had lower scores
on an index of substance use and other
behavioral risks than the control group
at 6 and 9 month follow-up. The overall
design is a 2 group (treatment and
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
( in hours)
Total annual
burden hour
Form name
Type of respondent
Screening ..........................................
Baseline ............................................
Follow-up Outcome Assessments (6
and 9 month).
Consent Form ...................................
Military Personnel .............................
Military Personnel .............................
Military Personnel .............................
1,624
812
812
1
1
2
10/60
30/60
30/60
271
406
812
Military Personnel .............................
821
1
5/60
68
Dated: February 19, 2016.
Genevieve R. deAlmeida,
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2016–04364 Filed 2–29–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of HHS-Certified
Laboratories and Instrumented Initial
Testing Facilities Which Meet Minimum
Standards To Engage in Urine Drug
Testing for Federal Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
asabaliauskas on DSK5VPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
The Department of Health and
Human Services (HHS) notifies federal
agencies of the laboratories and
Instrumented Initial Testing Facilities
(IITF) currently certified to meet the
standards of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908);
September 30, 1997 (62 FR 51118);
April 13, 2004 (69 FR 19644); November
25, 2008 (73 FR 71858); December 10,
SUMMARY:
VerDate Sep<11>2014
20:18 Feb 29, 2016
Jkt 238001
2008 (73 FR 75122); and on April 30,
2010 (75 FR 22809).
A notice listing all currently HHScertified laboratories and IITFs is
published in the Federal Register
during the first week of each month. If
any laboratory or IITF certification is
suspended or revoked, the laboratory or
IITF will be omitted from subsequent
lists until such time as it is restored to
full certification under the Mandatory
Guidelines.
If any laboratory or IITF has
withdrawn from the HHS National
Laboratory Certification Program (NLCP)
during the past month, it will be listed
at the end and will be omitted from the
monthly listing thereafter.
This notice is also available on the
Internet at https://www.samhsa.gov/
workplace.
Giselle Hersh, Division of Workplace
Programs, SAMHSA/CSAP, 5600
Fishers Lane, Room 16N03A, Rockville,
Maryland 20857; 240–276–2600 (voice).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were initially
developed in accordance with Executive
Order 12564 and section 503 of Public
Law 100–71. The ‘‘Mandatory
Guidelines for Federal Workplace Drug
Testing Programs,’’ as amended in the
revisions listed above, requires strict
standards that laboratories and IITFs
must meet in order to conduct drug and
specimen validity tests on urine
specimens for federal agencies.
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
To become certified, an applicant
laboratory or IITF must undergo three
rounds of performance testing plus an
on-site inspection. To maintain that
certification, a laboratory or IITF must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories and IITFs in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A HHS-certified
laboratory or IITF must have its letter of
certification from HHS/SAMHSA
(formerly: HHS/NIDA), which attests
that it has met minimum standards.
In accordance with the Mandatory
Guidelines dated November 25, 2008
(73 FR 71858), the following HHScertified laboratories and IITFs meet the
minimum standards to conduct drug
and specimen validity tests on urine
specimens:
HHS-Certified Instrumented Initial
Testing Facilities
Dynacare, 6628 50th Street NW.,
Edmonton, AB Canada T6B 2N7, 780–
784–1190 (Formerly: GammaDynacare Medical Laboratories)
HHS-Certified Laboratories
ACM Medical Laboratory, Inc., 160
Elmgrove Park, Rochester, NY 14624,
585–429–2264
Aegis Analytical Laboratories, Inc., 345
Hill Ave., Nashville, TN 37210, 615–
255–2400 (Formerly: Aegis Sciences
E:\FR\FM\01MRN1.SGM
01MRN1
]]>Agencies
[Federal Register Volume 81, Number 40 (Tuesday, March 1, 2016)]
[Notices]
[Pages 10639-10640]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04364]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; iWin: Navigating
Your Path to Well-Being
Summary: In compliance with the requirement of Section
3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity
for public comment on proposed data collection projects, the National
Institute on Drug Abuse (NIDA), National Institutes of Health (NIH),
will publish periodic summaries of proposed projects to be submitted to
the Office of Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited to address one or more of the following points:
(1) Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) Ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) Ways to minimize the burden of the
collection of information on those who are to respond, including the
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
To Submit Comments And For Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request more information on the proposed project, contact: Dr.
Belinda Sims, Health Scientist, DESPR, PRB, NIDA, NIH, 6001 Executive
Boulevard, Room 5153, Bethesda, Maryland 20892, or call non-toll-free
number (301) 402-1533, or Email your request, including your address
to: bsims@nida.nih.gov. Formal requests for additional plans and
instruments must be requested in writing.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: iWin: Navigating your Path to Well-Being,
0925-NEW, National Institute on Drug Abuse (NIDA), National Institutes
of Health (NIH).
Need and Use of Information Collection: The overarching objective
of this proposal is to conduct a
[[Page 10640]]
randomized trial to evaluate the effectiveness of the Individual Well-
Being Navigator (iWin) mobile application, a substance abuse prevention
and well-being enhancement program designed specifically for military
personnel. This mobile application provides an innovative, tailored
mobile application using best practices in behavior change science and
innovative technology to assist military personnel in preventing
substance abuse and enhancing well-being by providing them with the
most appropriate intervention content at the right time. It integrates
Trans-theoretical Model of Behavior Change based tailoring, SMS
messaging, stage of change matched activities, and engaging game-like
features in a cutting edge multiple behavior change program. The first
year of this project will focus on the completion of development and
beta testing of the app. In year 2, the efficacy of the iWin program
will be determined by tests of statistical significance indicating that
participants in the Treatment condition had lower scores on an index of
substance use and other behavioral risks than the control group at 6
and 9 month follow-up. The overall design is a 2 group (treatment and
control group) by 3 Occasions with repeated measures across occasions.
Once shown to be effective, the iWin program will assist organizations
that serve military personnel to meet the directives of both the
Department of Defense and the Chairman of the Joint Chiefs of Staff
indicating that prevention programs be evidence based, evaluated by the
specified populations and address full Total Force Fitness paradigm
rather than a single behavior.
OMB approval is requested for 1 year. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 1,557.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Type of Number of Number of burden per Total annual
Form name respondent respondents responses per response ( in burden hour
respondent hours)
----------------------------------------------------------------------------------------------------------------
Screening..................... Military 1,624 1 10/60 271
Personnel.
Baseline...................... Military 812 1 30/60 406
Personnel.
Follow-up Outcome Assessments Military 812 2 30/60 812
(6 and 9 month). Personnel.
Consent Form.................. Military 821 1 5/60 68
Personnel.
----------------------------------------------------------------------------------------------------------------
Dated: February 19, 2016.
Genevieve R. deAlmeida,
Project Clearance Liaison, NIDA, NIH.
[FR Doc. 2016-04364 Filed 2-29-16; 8:45 am]
BILLING CODE 4140-01-P
